Evidence map›Paper›PMID 31313901›Full record

ArticleACS applied materials & interfaces2019

Significant Suppression of

Ben Zhang, Benjamin M Braun, Jordan D Skelly, David C Ayers, Jie Song

Open access · greenAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ben ZhangDepartment of Orthopedics & Physical Rehabilitation , University of Massachusetts Medical School , Worcester , Massachusetts 01655 , United States.
Benjamin M BraunDepartment of Orthopedics & Physical Rehabilitation , University of Massachusetts Medical School , Worcester , Massachusetts 01655 , United States.
Jordan D SkellyDepartment of Orthopedics & Physical Rehabilitation , University of Massachusetts Medical School , Worcester , Massachusetts 01655 , United States.
David C AyersDepartment of Orthopedics & Physical Rehabilitation , University of Massachusetts Medical School , Worcester , Massachusetts 01655 , United States.
Jie SongDepartment of Orthopedics & Physical Rehabilitation , University of Massachusetts Medical School , Worcester , Massachusetts 01655 , United States.ORCID http://orcid.org/0000-0001-7554-5564
University of Massachusetts Chan Medical School · US

Funding

Implant surface modification strategies against periprosthetic infectionsR01AR068418 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SONG, JIE · 2015 to 2019
$1.8M
NIAMS NIH HHS R01 AR068418
6 · The paper itself

Abstract

Orthopedic implant-associated bacterial infection presents a major health threat due to tendency for periprosthetic bacterial colonization/biofilm formation that protects bacteria from host immune response and conventional antibiotic treatment. Using surface-initiated atom transfer radical polymerization and copper-catalyzed azide-alkyne cycloaddition (CuAAC), alkynylated vancomycin is conjugated to azido-functionalized side chains of polymethacrylates grafted from Ti6Al4V. High-efficiency CuAAC across the substrate is confirmed by complete surface conversion of azides by X-ray photoelectron spectroscopy (XPS) and elemental mapping of changing characteristic elements. The vancomycin-modified surface (Ti-pVAN) significantly reduces in vitro adhesion and colonization of

Indexed as

Anti-Bacterial AgentsCoated Materials, BiocompatibleTitaniumAlloysAnimalsBiofilmsMiceProstheses and ImplantsStaphylococcal InfectionsStaphylococcus aureusVancomycinAlloysAnti-Bacterial AgentsCoated Materials, BiocompatibleTitaniumtitanium alloy (TiAl6V4)Vancomycincopper-catalyzed azide−alkyne cycloadditionperiprosthetic infectionsurface-initiated atom transfer radical polymerizationvancomycin

Identifiers

PMID31313901
PMCPMC8086729
OpenAlexW2961198371

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.